These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 36640848)
1. Antifungal activity and potential mechanism of action of caspofungin in combination with ribavirin against Candida albicans. Wang Y; Yan H; Li J; Zhang Y; Wang Z; Sun S Int J Antimicrob Agents; 2023 Mar; 61(3):106709. PubMed ID: 36640848 [TBL] [Abstract][Full Text] [Related]
2. Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence. Zhang M; Yan H; Lu M; Wang D; Sun S Int J Antimicrob Agents; 2020 Jan; 55(1):105804. PubMed ID: 31605727 [TBL] [Abstract][Full Text] [Related]
3. Antifungal activity and potential mechanism of Asiatic acid alone and in combination with fluconazole against Candida albicans. Wang Y; Lu C; Zhao X; Wang D; Liu Y; Sun S Biomed Pharmacother; 2021 Jul; 139():111568. PubMed ID: 33845374 [TBL] [Abstract][Full Text] [Related]
4. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
5. Caspofungin Inhibits Mixed Biofilms of Candida albicans and Methicillin-Resistant Staphylococcus aureus and Displays Effectiveness in Coinfected Galleria mellonella Larvae. Scheunemann G; Fortes BN; Lincopan N; Ishida K Microbiol Spectr; 2021 Oct; 9(2):e0074421. PubMed ID: 34643410 [TBL] [Abstract][Full Text] [Related]
6. Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A. Shinde RB; Chauhan NM; Raut JS; Karuppayil SM Ann Clin Microbiol Antimicrob; 2012 Oct; 11():27. PubMed ID: 23035934 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm. Pesee S; Angkananuwat C; Tancharoensukjit S; Muanmai S; Sirivan P; Bubphawas M; Tanarerkchai N Med Mycol; 2016 May; 54(4):384-93. PubMed ID: 26768371 [TBL] [Abstract][Full Text] [Related]
8. Synergistic Activity of the Human Lactoferricin-Derived Peptide hLF1-11 in Combination with Caspofungin against Fais R; Rizzato C; Franconi I; Tavanti A; Lupetti A Microbiol Spectr; 2022 Aug; 10(4):e0124022. PubMed ID: 35876581 [No Abstract] [Full Text] [Related]
9. In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms. Miceli MH; Bernardo SM; Lee SA Int J Antimicrob Agents; 2009 Oct; 34(4):326-32. PubMed ID: 19515537 [TBL] [Abstract][Full Text] [Related]
10. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms. Cocuaud C; Rodier MH; Daniault G; Imbert C J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622 [TBL] [Abstract][Full Text] [Related]
11. Micafungin triggers caspase-dependent apoptosis in Candida albicans and Candida parapsilosis biofilms, including caspofungin non-susceptible isolates. Shirazi F; Kontoyiannis DP Virulence; 2015; 6(4):385-94. PubMed ID: 26065323 [TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms. Kovács R; Nagy F; Tóth Z; Bozó A; Balázs B; Majoros L Lett Appl Microbiol; 2019 Oct; 69(4):271-278. PubMed ID: 31385615 [TBL] [Abstract][Full Text] [Related]
13. Caspofungin resistance in Candida albicans: genetic factors and synergistic compounds for combination therapies. Perrine-Walker F Braz J Microbiol; 2022 Sep; 53(3):1101-1113. PubMed ID: 35352319 [TBL] [Abstract][Full Text] [Related]
14. Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates. Walraven CJ; Bernardo SM; Wiederhold NP; Lee SA Med Mycol; 2014 Feb; 52(2):131-139. PubMed ID: 24576999 [TBL] [Abstract][Full Text] [Related]
15. In vitro activity of antifungal combinations against Candida albicans biofilms. Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142 [TBL] [Abstract][Full Text] [Related]
16. Aspirin and verapamil increase the sensitivity of Candida albicans to caspofungin under planktonic and biofilm conditions. Feng W; Yang J; Ma Y; Xi Z; Ren Q; Wang S; Ning H J Glob Antimicrob Resist; 2021 Mar; 24():32-39. PubMed ID: 33242673 [TBL] [Abstract][Full Text] [Related]
17. The synergistic antifungal effects of gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm formation. Liu Y; Ren H; Wang D; Zhang M; Sun S; Zhao Y Biomed Pharmacother; 2020 Oct; 130():110580. PubMed ID: 32745913 [TBL] [Abstract][Full Text] [Related]
18. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms. Delattin N; De Brucker K; Vandamme K; Meert E; Marchand A; Chaltin P; Cammue BP; Thevissen K J Antimicrob Chemother; 2014 Apr; 69(4):1035-44. PubMed ID: 24284780 [TBL] [Abstract][Full Text] [Related]